| William Ellsworth Tarr Jr, MD | |
|
1 Malcolm Ave, Quest Diagnostics Inc, Teterboro, NJ 07608-1011 | |
| (201) 393-5752 | |
| Not Available |
| Full Name | William Ellsworth Tarr Jr |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 1 Malcolm Ave, Teterboro, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285833814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 25MA07021700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| William Ellsworth Tarr Jr, MD 1 Malcolm Ave, Quest Diagnostics Inc, Teterboro, NJ 07608-1011 Ph: (201) 393-5752 | William Ellsworth Tarr Jr, MD 1 Malcolm Ave, Quest Diagnostics Inc, Teterboro, NJ 07608-1011 Ph: (201) 393-5752 |
News Archive
Blood tests convey vital medical information, but the sight of a needle often causes anxiety and results take time. A new device developed by a team of researchers in Israel, however, can reveal much the same information as traditional blood test in real-time, simply by shining a light through the skin.
Researchers from the Peninsula Medical School in Plymouth (UK), the Memorial Sloan-Kettering Cancer Center in New York, Cornell University in New York, Weil Medical College in New York and the Center for Neural Tumour Research in Los Angeles, have for the first time identified a key mechanism that makes certain cells become tumorous in the brain. The resulting tumours occur most often spontaneously but can also occur in numbers as part of the inherited disease Neurofibromatosis type 2.
The British Veterinary Association (BVA) has warned that vets should take hospital-style precautions to avoid passing the MRSA "superbug" to animals, and should use sterile gloves, scrub suits and masks during operations to protect the animals.
An Indiana University School of Optometry researcher's ongoing work to improve testing for and treatment of one of the world's leading causes of blindness will advance with support from a $2.35 million grant from the National Institutes of Health.
Ampio Pharmaceuticals, Inc., a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced today that it reached agreement with the Therapeutic Goods Administration, Canberra, Australia, on a plan of drug manufacture and quality control for Zertane and the overall plan for the preparation of Common Technical Documents for the draft registration submission expected to be filed in June 2012.
› Verified 2 days ago
Marina Gerber, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-5357 Fax: 201-462-4712 | |
Leza N Gallo, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, 1 Malcolm Avenue, Teterboro, NJ 07608 Phone: 201-393-5035 | |
Dr. Uma Ayer, M.D Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07606 Phone: 203-393-5606 | |
Xinzhu Pang, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Quest Diagnostics, One Malcolm Ave, Teterboro, NJ 07068 Phone: 201-893-5632 | |
Dr. Ronald David Luff, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6007 Fax: 201-462-4772 | |
Ecaterina F Tamas, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 1 Malcolm Ave, Teterboro, NJ 07608 Phone: 201-393-6317 |